marketcaparena

CLVT

CLARIVATE PLC

Company overview

Market capitalization
$1.09B
Employees
12,000
Latest publication
2026-09-29
About CLARIVATE PLC

Clarivate Plc provides information services in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. The company offers scientific and academic research solutions; Web of Science Research Intelligence, an AI-native solution; ProQuest solutions to access multidisciplinary curated content, such as databases, dissertations, news, primary sources, books, and video formats; library software, including Alma, library services platform; and Vega and Polaris for public libraries. It also provides patent maintenance and administrative services; Derwent Innovation, an AI-powered search; Derwent World Patents Index to identify related concepts in patent publications and navigate new or unfamiliar technology categories; CompuMark, a trademark search and watch solutions; IP Recordals managed services; and RiskMark, an AI-powered tool for evaluating trademark risk and argument drafting support. In addition, the company offers IPfolio, a management platform; FoundationIP solution for law firms; Cortellis for decisions related to assessing the market, analyzing competitors, regulatory compliance, and drug safety; Regulatory Intelligence platform; commercial solutions; and Medtech solutions. It serves academic institutions, government agencies, and life sciences, and pharmaceutical companies. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ3 20242024-09-30 · USDQ1 20242024-03-31 · USDQ4 20232023-12-31 · USD
Total Revenue587,300,000USD585,500,000USD617,000,000USD623,100,000USD621,400,000USD622,200,000USD621,200,000USD683,700,000USD
Cost Of Revenue185,500,000USD192,100,000USD204,800,000USD218,200,000USD203,600,000USD210,100,000USD217,800,000USD412,400,000USD
Gross Profit401,800,000USD393,400,000USD412,200,000USD404,900,000USD417,800,000USD412,100,000USD403,400,000USD271,300,000USD
Selling General Administrative181,600,000USD176,300,000USD179,100,000USD170,000,000USD181,100,000USD169,700,000USD191,900,000USD180,400,000USD
Total Operating Expenses602,000,000USD363,200,000USD370,800,000USD360,900,000USD410,900,000USD390,400,000USD398,400,000USD180,400,000USD
Operating Income-200,200,000USD30,200,000USD41,400,000USD44,000,000USD6,900,000USD21,700,000USD5,000,000USD90,900,000USD
Total Other Income Expense Net-60,400,000USD-59,000,000USD-66,000,000USD-68,500,000USD-66,600,000USD-72,200,000USD-65,000,000USD-952,800,000USD
Depreciation And Amortization185,700,000USD184,000,000USD189,100,000USD191,800,000USD190,900,000USD177,200,000USD179,400,000USD180,800,000USD
Income Before Tax-260,600,000USD-28,800,000USD-24,600,000USD-24,500,000USD-59,700,000USD-50,500,000USD-60,000,000USD-861,900,000USD
Income Tax Expense8,000,000USD11,400,000USD-27,700,000USD3,800,000USD12,300,000USD15,100,000USD15,000,000USD-18,000,000USD
Net Income-268,600,000USD-40,200,000USD3,100,000USD-28,300,000USD-72,000,000USD-65,600,000USD-75,000,000USD-843,900,000USD
Unclassified Operating Expenses—186,900,000USD191,700,000USD190,900,000USD229,800,000USD220,700,000USD206,500,000USD—
Interest Expense—59,000,000USD66,000,000USD68,500,000USD66,600,000USD72,200,000USD70,200,000USD75,200,000USD
Net Interest Income—-59,000,000USD-66,000,000USD-68,500,000USD-66,600,000USD-72,200,000USD-70,200,000USD-75,200,000USD
Tax Provision—11,400,000USD-27,700,000USD3,800,000USD12,300,000USD15,100,000USD15,000,000USD-18,000,000USD
Net Income From Continuing Ops—-40,200,000USD3,100,000USD-28,300,000USD-72,000,000USD-65,600,000USD-75,000,000USD-843,900,000USD
Ebit—29,600,000USD41,400,000USD44,700,000USD57,000,000USD21,700,000USD10,200,000USD-786,700,000USD
Ebitda—213,600,000USD230,500,000USD236,500,000USD247,900,000USD198,900,000USD189,600,000USD-605,900,000USD
Reconciled Depreciation—184,000,000USD189,100,000USD191,800,000USD190,900,000USD177,200,000USD179,400,000USD180,800,000USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20222022-12-31 · USDFY 20162016-12-31 · USDFY 20152015-12-31 · USDFY 20142014-12-31 · USD
Total Revenue2,455,200,000USD2,659,800,000USD514,246,000USD535,004,000USD555,103,000USD
Cost Of Revenue833,600,000USD954,000,000USD346,398,000USD343,522,000USD363,014,000USD
Gross Profit1,621,600,000USD1,705,800,000USD167,848,000USD191,482,000USD192,089,000USD
Selling General Administrative708,600,000USD729,900,000USD99,815,000USD84,810,000USD80,860,000USD
Unclassified Operating Expenses841,500,000USD385,700,000USD-105,256,000USD-91,235,000USD—
Total Operating Expenses1,550,100,000USD1,115,600,000USD0USD0USD117,484,000USD
Operating Income71,500,000USD-3,925,600,000USD24,522,000USD64,794,000USD74,605,000USD
Interest Expense265,399,999USD270,300,000USD0USD0USD0USD
Net Interest Income-265,400,000USD-270,300,000USD———
Income Before Tax-193,900,000USD-3,989,100,000USD20,073,000USD63,386,000USD72,508,000USD
Income Tax Expense7,200,000USD-28,900,000USD6,276,000USD19,923,000USD23,138,000USD
Tax Provision7,200,000USD-28,900,000USD———
Net Income-201,100,000USD-3,960,200,000USD13,797,000USD43,463,000USD49,370,000USD
Net Income From Continuing Ops-201,100,000USD-3,960,200,000USD13,797,000USD43,463,000USD49,370,000USD
Ebit172,100,000USD590,200,000USD22,458,000USD64,159,000USD72,771,000USD
Ebitda929,300,000USD1,300,700,000USD———
Depreciation And Amortization757,200,000USD710,500,000USD———
Reconciled Depreciation757,200,000USD710,500,000USD———
Total Other Income Expense Net-265,400,000USD-4,309,000,000USD-2,064,000USD-635,000USD-1,834,000USD
Non Operating Income Net Other—206,800,000USD———
Net Income Applicable To Common Shares—-4,035,600,000USD13,797,000USD43,463,000USD49,370,000USD
Research Development——5,441,000USD6,425,000USD6,406,000USD
Other Operating Expenses————30,470,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Total Assets10,486,100,000USD10,927,100,000USD11,069,400,000USD11,227,600,000USD11,421,200,000USD11,492,700,000USD11,490,200,000USD12,030,600,000USD
Cash And Equivalents217,700,000USD———————
Total Current Assets1,214,200,000USD1,301,100,000USD1,310,000,000USD1,291,100,000USD1,340,200,000USD1,354,300,000USD1,244,600,000USD1,339,100,000USD
Other Current Assets61,500,000USD185,900,000USD159,100,000USD161,700,000USD157,200,000USD169,800,000USD151,100,000USD178,800,000USD
Other Non Current Assets86,500,000USD———————
Total Liabilities5,948,600,000USD———————
Total Current Liabilities1,435,700,000USD1,542,100,000USD1,568,800,000USD1,489,600,000USD1,478,800,000USD1,540,600,000USD1,433,500,000USD1,525,600,000USD
Other Non Current Liabilities75,800,000USD———————
Total Stockholder Equity4,537,500,000USD4,788,800,000USD4,842,900,000USD4,903,800,000USD4,994,100,000USD5,027,100,000USD5,139,000,000USD5,513,500,000USD
Total Equity Including Noncontrolling Interest4,537,500,000USD———————
Long Term Debt4,209,300,000USD4,281,600,000USD4,321,500,000USD4,419,000,000USD4,516,800,000USD4,521,100,000USD4,518,700,000USD4,632,500,000USD
Deferred Revenue897,000,000USD———————
Net Receivables827,900,000USD882,900,000USD821,700,000USD810,700,000USD820,400,000USD830,500,000USD798,300,000USD771,800,000USD
Property Plant Equipment Net88,300,000USD93,400,000USD99,300,000USD102,600,000USD109,500,000USD110,400,000USD107,100,000USD105,400,000USD
Goodwill1,344,900,000USD———————
Intangible Assets7,734,300,000USD7,863,700,000USD8,008,100,000USD8,149,000,000USD8,284,000,000USD8,341,400,000USD8,441,200,000USD8,726,700,000USD
Accounts Payable152,900,000USD135,700,000USD150,600,000USD139,700,000USD125,700,000USD120,000,000USD124,500,000USD126,500,000USD
Short Term Debt16,700,000USD19,100,000USD119,900,000USD37,400,000USD40,200,000USD42,000,000USD41,200,000USD44,200,000USD
Common Stock12,815,200,000USD12,801,300,000USD12,810,600,000USD12,867,900,000USD12,902,700,000USD12,935,100,000USD12,978,800,000USD13,069,000,000USD
Retained Earnings-7,823,400,000USD-7,554,800,000USD-7,514,600,000USD-7,517,700,000USD-7,489,400,000USD-7,417,400,000USD-7,313,500,000USD-7,121,700,000USD
Accumulated Other Comprehensive Income-454,300,000USD-457,700,000USD-453,100,000USD-446,400,000USD-419,200,000USD-490,600,000USD-526,300,000USD-433,800,000USD
Total Liab—6,138,300,000USD6,226,500,000USD6,323,800,000USD6,427,100,000USD6,465,600,000USD6,351,200,000USD6,517,100,000USD
Other Current Liab—386,900,000USD356,900,000USD439,700,000USD383,800,000USD399,800,000USD408,700,000USD464,700,000USD
Capital Stock—12,801,300,000USD12,810,600,000USD12,867,900,000USD12,902,700,000USD12,935,100,000USD12,978,800,000USD13,069,000,000USD
Good Will—1,566,600,000USD1,566,700,000USD1,566,700,000USD1,566,900,000USD1,566,600,000USD1,566,600,000USD1,736,800,000USD
Cash—232,300,000USD329,200,000USD318,700,000USD362,600,000USD354,000,000USD295,200,000USD388,500,000USD
Cash And Short Term Investments—232,300,000USD329,200,000USD318,700,000USD362,600,000USD354,000,000USD295,200,000USD388,500,000USD
Current Deferred Revenue—1,000,400,000USD941,400,000USD872,800,000USD929,100,000USD978,800,000USD859,100,000USD890,200,000USD
Net Debt—4,102,100,000USD4,150,100,000USD4,161,100,000USD4,224,100,000USD4,241,300,000USD4,297,300,000USD4,324,000,000USD
Short Long Term Debt—1,500,000USD101,500,000USD———1,300,000USD—
Short Long Term Debt Total—4,334,400,000USD4,479,300,000USD4,479,800,000USD4,586,700,000USD4,595,300,000USD4,592,500,000USD4,712,500,000USD
Property Plant Equipment Gross—93,400,000USD199,700,000USD102,600,000USD109,500,000USD110,400,000USD196,300,000USD105,400,000USD
Common Stock Shares Outstanding—640,700,000shares662,300,000shares668,300,000shares681,300,000shares689,800,000shares702,800,000shares718,700,000shares
Non Current Assets Total—9,626,000,000USD9,759,400,000USD9,936,500,000USD10,081,000,000USD10,138,400,000USD10,245,600,000USD10,691,500,000USD
Non Current Liabilities Total—4,596,200,000USD4,657,700,000USD4,834,200,000USD4,948,300,000USD4,925,000,000USD4,917,700,000USD4,991,500,000USD
Non Current Liabilities Other—75,900,000USD86,200,000USD98,600,000USD97,400,000USD74,900,000USD55,900,000USD52,500,000USD
Non Currrent Assets Other—71,700,000USD66,300,000USD63,100,000USD62,400,000USD61,800,000USD67,500,000USD64,400,000USD
Net Working Capital—-241,000,000USD-258,800,000USD-198,500,000USD-138,600,000USD-186,300,000USD-188,900,000USD-186,500,000USD
Unclassified Non Current Liabilities—238,700,000USD250,000,000USD316,600,000USD334,100,000USD329,000,000USD343,100,000USD306,500,000USD
Unclassified Equity—-12,801,300,000USD-12,810,600,000USD-12,867,900,000USD-12,902,700,000USD-12,935,100,000USD-12,978,800,000USD-13,069,000,000USD
Unclassified Current Liabilities——-101,500,000USD—————
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Assets11,069,400,000USD11,490,200,000USD12,706,800,000USD13,944,900,000USD20,182,979,000USD15,197,344,000USD3,791,371,000USD3,709,674,000USD
Intangible Assets8,008,100,000USD8,441,200,000USD9,006,600,000USD9,437,700,000USD10,392,354,000USD7,370,350,000USD1,828,640,000USD1,958,520,000USD
Other Current Assets159,100,000USD151,100,000USD183,200,000USD76,900,000USD143,197,000USD318,829,000USD83,088,000USD51,742,000USD
Total Liab6,226,500,000USD6,351,200,000USD6,714,500,000USD7,132,400,000USD8,257,110,000USD5,603,373,000USD2,542,772,000USD2,659,067,000USD
Total Stockholder Equity4,842,900,000USD5,139,000,000USD5,992,300,000USD6,812,500,000USD11,925,869,000USD9,593,971,000USD1,248,599,000USD1,050,607,000USD
Other Current Liab356,900,000USD322,600,000USD448,400,000USD484,200,000USD651,065,001USD742,773,000USD179,091,000USD153,849,000USD
Common Stock12,810,600,000USD12,978,800,000USD11,740,500,000USD11,744,700,000USD11,827,915,000USD10,049,317,000USD2,144,372,000USD16,000USD
Capital Stock12,810,600,000USD12,978,800,000USD13,133,100,000USD13,137,300,000USD13,220,531,000USD10,049,317,000USD2,208,529,000USD16,000USD
Retained Earnings-7,514,600,000USD-7,313,500,000USD-6,645,500,000USD-5,658,900,000USD-1,604,461,000USD-958,867,000USD-890,894,000USD-632,261,000USD
Good Will1,566,700,000USD1,566,600,000USD2,023,700,000USD2,876,500,000USD7,904,863,000USD6,252,636,000USD1,328,045,000USD1,282,919,000USD
Cash329,200,000USD295,200,000USD370,700,000USD348,800,000USD587,613,000USD257,730,000USD76,130,000USD25,575,000USD
Cash And Short Term Investments329,200,000USD295,200,000USD370,700,000USD348,800,000USD587,613,000USD257,730,000USD76,130,000USD25,575,000USD
Total Current Assets1,310,000,000USD1,244,600,000USD1,462,200,000USD1,395,200,000USD1,637,238,000USD1,328,005,000USD493,076,000USD408,612,000USD
Total Current Liabilities1,568,800,000USD1,433,500,000USD1,600,000,000USD1,559,800,000USD1,901,974,000USD1,569,767,000USD650,998,000USD643,714,000USD
Current Deferred Revenue941,400,000USD943,900,000USD983,100,000USD947,500,000USD1,030,398,999USD707,318,000USD407,325,000USD391,102,000USD
Net Debt4,150,100,000USD4,297,300,000USD4,438,000,000USD4,755,800,000USD5,025,376,000USD3,228,770,000USD1,647,800,000USD1,964,947,000USD
Short Term Debt119,900,000USD42,500,000USD24,400,000USD26,700,000USD62,754,000USD35,455,000USD31,130,000USD60,345,000USD
Short Long Term Debt101,500,000USD1,300,000USD—1,000,000USD30,577,000USD28,600,000USD9,000,000USD60,345,000USD
Short Long Term Debt Total4,479,300,000USD4,592,500,000USD4,808,700,000USD5,104,600,000USD5,612,989,000USD3,493,355,000USD1,723,930,000USD1,990,522,000USD
Long Term Debt4,321,500,000USD4,518,700,000USD4,721,100,000USD5,005,000,000USD3,457,900,000USD3,457,900,000USD1,628,611,000USD1,930,177,000USD
Net Receivables821,700,000USD798,300,000USD908,300,000USD872,100,000USD906,428,000USD751,446,000USD333,858,000USD331,295,000USD
Accounts Payable150,600,000USD124,500,000USD144,100,000USD101,400,000USD129,217,999USD798,394,000USD26,458,000USD38,418,000USD
Property Plant Equipment Net99,300,000USD107,100,000USD106,800,000USD113,400,000USD169,876,000USD168,623,000USD103,490,000USD20,641,000USD
Property Plant Equipment Gross199,700,000USD196,300,000USD180,400,000USD113,400,000USD169,876,000USD36,267,000USD103,490,000USD20,641,000USD
Accumulated Other Comprehensive Income-453,100,000USD-526,300,000USD-495,300,000USD-665,900,000USD326,755,000USD503,521,000USD-4,879,000USD5,358,000USD
Common Stock Shares Outstanding673,300,000shares693,600,000shares671,600,000shares678,600,000shares640,774,100shares273,883,342shares273,883,342shares305,250,000shares
Non Current Assets Total9,759,400,000USD10,245,600,000USD11,244,599,999USD12,549,700,000USD18,545,741,000USD13,659,253,000USD3,298,295,000USD3,301,062,000USD
Non Current Liabilities Total4,657,700,000USD4,917,700,000USD5,114,500,000USD5,572,600,000USD6,355,136,000USD137,721,000USD1,891,774,000USD2,015,353,000USD
Non Current Liabilities Other86,200,000USD55,900,000USD41,900,000USD251,500,000USD49,445,000USD213,445,000USD18,891,000USD24,838,000USD
Non Currrent Assets Other66,300,000USD67,500,000USD43,099,999USD50,700,000USD48,753,000USD216,567,000USD18,632,000USD26,556,000USD
Net Working Capital-258,800,000USD-188,900,000USD-137,800,000USD-164,600,000USD-264,736,000USD-241,762,000USD-157,922,000USD-235,102,000USD
Unclassified Current Liabilities-101,500,000USD————-742,773,000USD—-60,345,000USD
Unclassified Non Current Liabilities250,000,000USD343,100,000USD351,500,000USD-494,700,000USD1,675,894,000USD-4,367,267,000USD36,456,000USD-34,331,000USD
Unclassified Equity-12,810,600,000USD-12,978,800,000USD-11,740,500,000USD-11,744,700,000USD-11,844,871,000USD-10,049,317,000USD-2,208,529,000USD1,677,478,000USD
Other Assets——1USD122,100,000USD78,648,000USD77,730,000USD38,120,000USD38,982,000USD
Short Term Investments——2,300,000USD2,300,000USD————
Inventory——97,400,000USD97,400,000USD97,400,000USD70,048,000USD70,048,000USD31,030,000USD
Unclassified Current Assets——-99,700,000USD—-97,400,000USD-70,048,000USD-70,048,000USD-31,030,000USD
Deferred Long Term Liab———316,100,000USD366,996,000USD362,261,000USD11,620,000USD9,493,000USD
Other Liab———494,700,000USD804,901,000USD471,382,000USD196,196,000USD85,176,000USD
Net Tangible Assets———5,419,900,000USD-4,378,524,000USD-4,029,015,000USD-1,908,086,000USD-2,190,832,000USD
Unclassified Non Current Assets—————-426,653,000USD——
Long Term Investments——————3,644,000USD3,644,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USD
Net Income-40,200,000USD-28,300,000USD-72,000,000USD-103,900,000USD-191,800,000USD-65,600,000USD-304,300,000USD-75,000,000USD
Depreciation184,000,000USD191,800,000USD190,900,000USD185,400,000USD186,000,000USD177,200,000USD187,600,000USD184,100,000USD
Stock Based Compensation14,200,000USD16,100,000USD18,600,000USD10,700,000USD11,000,000USD15,000,000USD18,900,000USD15,400,000USD
Other Non Cash Items-13,500,000USD-14,500,000USD31,200,000USD24,500,000USD138,400,000USD38,200,000USD215,400,000USD3,300,000USD
Change To Account Receivables-62,300,000USD4,000,000USD35,800,000USD-33,600,000USD-55,600,000USD45,000,000USD28,400,000USD74,800,000USD
Change In Working Capital-9,800,000USD22,200,000USD-47,000,000USD54,500,000USD-52,300,000USD42,300,000USD8,600,000USD48,400,000USD
Total Cash From Operating Activities134,700,000USD181,100,000USD116,300,000USD171,200,000USD141,300,000USD202,900,000USD126,200,000USD176,200,000USD
Capital Expenditures-55,800,000USD-65,600,000USD-66,000,000USD-60,900,000USD-82,200,000USD-76,600,000USD-65,900,000USD-64,400,000USD
Free Cash Flow78,900,000USD115,500,000USD50,300,000USD110,300,000USD59,100,000USD126,300,000USD60,300,000USD111,799,999USD
Total Cashflows From Investing Activities-55,800,000USD-65,600,000USD-66,000,000USD-60,900,000USD21,400,000USD-91,500,000USD-102,200,000USD-64,400,000USD
Net Borrowings-138,500,000USD-100,000,000USD0USD0USD-139,300,000USD-5,400,000USD——
Total Cash From Financing Activities-162,300,000USD-154,700,000USD-53,900,000USD-56,600,000USD-239,600,000USD-109,700,000USD-25,600,000USD-95,200,000USD
Sale Purchase Of Stock-18,100,000USD-50,000,000USD-49,500,000USD-50,000,000USD-100,000,000USD-100,000,000USD-1,300,000USD-8,600,000USD
Change In Cash-87,000,000USD-43,900,000USD8,600,000USD58,800,000USD-93,300,000USD12,100,000USD-4,600,000USD10,300,000USD
Begin Period Cash Flow329,200,000USD362,600,000USD354,000,000USD295,200,000USD388,500,000USD376,400,000USD381,000,000USD370,700,000USD
End Period Cash Flow242,200,000USD318,700,000USD362,600,000USD354,000,000USD295,200,000USD388,500,000USD376,400,000USD381,000,000USD
Other Cashflows From Financing Activities-5,700,000USD-3,700,000USD4,100,000USD-6,600,000USD-300,000USD-4,000,000USD-200,000USD-20,300,000USD
Investments—-65,600,000USD-66,000,000USD-60,900,000USD21,400,000USD-91,500,000USD-102,200,000USD-64,400,000USD
Dividends Paid—0USD0USD0USD0USD0USD-18,800,000USD-18,900,000USD
Unclassified Operating Cash Flow—-6,200,000USD-5,400,000USD—50,000,000USD-4,200,000USD——
Unclassified Investing Cash Flow—65,600,000USD66,000,000USD60,900,000USD82,200,000USD95,800,000USD85,100,000USD64,400,000USD
Unclassified Financing Cash Flow——-8,500,000USD———-5,300,000USD-47,400,000USD
Other Cashflows From Investing Activities—————-19,200,000USD-19,200,000USD—
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Net Income-201,100,000USD-636,700,000USD-911,200,000USD-3,960,200,000USD-3,960,200,000USD-270,448,000USD-258,632,999USD-242,162,000USD
Depreciation757,200,000USD727,000,000USD708,300,000USD710,500,000USD710,500,000USD537,815,000USD200,542,000USD237,225,000USD
Stock Based Compensation63,100,000USD59,900,000USD109,000,000USD93,900,000USD93,900,000USD33,329,000USD51,383,000USD13,715,000USD
Other Non Cash Items47,300,000USD500,100,000USD976,900,000USD3,991,300,000USD3,991,300,000USD-31,650,000USD120,216,000USD-27,394,000USD
Change To Account Receivables-5,000,000USD92,600,000USD-25,500,000USD-28,300,000USD-28,300,000USD-64,067,000USD-593,000USD-50,906,000USD
Change In Working Capital3,500,000USD-24,900,000USD-60,400,000USD-271,900,000USD-271,900,000USD68,079,000USD3,715,000USD-27,200,000USD
Total Cash From Operating Activities628,500,000USD646,600,000USD744,200,000USD509,300,000USD509,300,000USD323,767,000USD117,580,000USD-26,100,000USD
Capital Expenditures-263,200,000USD-289,100,000USD-242,500,000USD-202,900,000USD-202,900,000USD-118,543,000USD-69,836,000USD-45,410,000USD
Free Cash Flow365,300,000USD357,500,000USD501,700,000USD306,400,000USD306,400,000USD205,224,000USD47,744,000USD-71,510,000USD
Total Cashflows From Investing Activities-263,200,000USD-236,700,000USD-237,400,000USD57,300,000USD-2,988,768,000USD-2,992,168,000USD-140,885,000USD11,934,000USD
Net Borrowings-100,000,000USD-198,100,000USD-300,000,000USD-498,600,000USD-115,940,000USD-115,940,000USD978,491,000USD-31,709,000USD
Total Cash From Financing Activities-343,100,000USD-470,100,000USD-496,500,000USD-759,200,000USD-759,200,000USD4,032,160,000USD75,215,000USD-32,605,000USD
Dividends Paid0USD-37,700,000USD-75,500,000USD-75,400,000USD-75,400,000USD-18,868,000USD-18,868,000USD-18,868,000USD
Sale Purchase Of Stock-224,500,000USD-200,000,000USD-100,000,000USD-175,000,000USD-175,000,000USD-159,356,000USD1,582,000USD1,574,000USD
Change In Cash34,000,000USD-75,500,000USD13,900,000USD-230,800,000USD-230,800,000USD315,205,000USD50,555,000USD-51,964,000USD
Begin Period Cash Flow295,200,000USD370,700,000USD356,800,000USD587,600,000USD587,600,000USD272,408,000USD25,584,000USD77,548,000USD
End Period Cash Flow329,200,000USD295,200,000USD370,700,000USD356,800,000USD356,800,000USD587,613,000USD76,139,000USD25,584,000USD
Other Cashflows From Investing Activities-263,200,000USD84,400,000USD285,000,000USD260,200,000USD-2,881,055,000USD-2,884,455,000USD-2,625,000USD80,883,000USD
Other Cashflows From Financing Activities-9,200,000USD-34,300,000USD-20,000,000USD-16,100,000USD-16,100,000USD3,528,662,000USD479,716,000USD-896,000USD
Unclassified Operating Cash Flow-41,500,000USD21,200,000USD-78,400,000USD-54,300,000USD-54,300,000USD-13,358,000USD—19,716,000USD
Unclassified Investing Cash Flow263,200,000USD204,700,000USD-337,600,000USD-57,300,000USD4,139,647,000USD3,002,998,000USD72,461,000USD-35,473,000USD
Unclassified Financing Cash Flow-9,400,000USD———-376,760,000USD797,662,000USD-1,365,706,000USD17,294,000USD
Investments—-236,700,000USD57,700,000USD57,300,000USD-4,044,460,000USD-2,992,168,000USD-140,885,000USD11,934,000USD
Change To Inventory——-210,300,000USD-210,300,000USD100,746,000USD100,746,000USD-26,829,000USD8,258,000USD
Issuance Of Capital Stock——3,500,000USD5,700,000USD2,260,520,000USD843,744,000USD—1,574,000USD
Change To Liabilities———-162,200,000USD-54,075,000USD-90,961,000USD19,642,000USD15,448,000USD
Cash And Cash Equivalents Changes———-192,600,000USD201,312,000USD197,912,000USD——
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
Q2 2026Quarterly · 2026-06-30ProductRe Occurring Revenues109,300,000USDDisclosure
Q2 2026Quarterly · 2026-06-30ProductSubscription Revenues403,300,000USDDisclosure
Q2 2026Quarterly · 2026-06-30ProductTransactional Revenues74,700,000USDDisclosure
Q2 2026Quarterly · 2026-06-30SegmentAcademia Government Group300,300,000USDDisclosure
Q2 2026Quarterly · 2026-06-30SegmentIntellectual Property Group198,300,000USDDisclosure
Q2 2026Quarterly · 2026-06-30SegmentLife Sciences And Healthcare Group88,700,000USDDisclosure
Q1 2026Quarterly · 2026-03-31ProductRe Occurring Revenues108,600,000USD0001764046-26-000058
Q1 2026Quarterly · 2026-03-31ProductSubscription Revenues397,500,000USD0001764046-26-000058
Q1 2026Quarterly · 2026-03-31ProductTransactional Revenues79,400,000USD0001764046-26-000058
Q1 2026Quarterly · 2026-03-31SegmentAcademia Government Group295,000,000USD0001764046-26-000058
Q1 2026Quarterly · 2026-03-31SegmentIntellectual Property Group197,200,000USD0001764046-26-000058
Q1 2026Quarterly · 2026-03-31SegmentLife Sciences And Healthcare Group93,300,000USD0001764046-26-000058
Q4 2025Quarterly · 2025-12-31ProductRe Occurring Revenues114,100,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductSubscription Revenues405,800,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductTransactional Revenues97,100,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31SegmentAcademia Government Group312,300,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31SegmentIntellectual Property Group206,400,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31SegmentLife Sciences And Healthcare Group98,300,000USDLegacy provider
FY 2025Yearly · 2025-12-31GeographyAsia Pacific497,400,000USD0001764046-26-000019
FY 2025Yearly · 2025-12-31GeographyEMEA654,800,000USD0001764046-26-000019
FY 2025Yearly · 2025-12-31GeographyNorth America1,303,000,000USD0001764046-26-000019
FY 2025Yearly · 2025-12-31ProductRe Occurring Revenues434,200,000USD0001764046-26-000019
FY 2025Yearly · 2025-12-31ProductSubscription Revenues1,605,500,000USD0001764046-26-000019
FY 2025Yearly · 2025-12-31ProductTransactional Revenues415,500,000USD0001764046-26-000019
FY 2025Yearly · 2025-12-31SegmentAcademia Government Group1,266,000,000USD0001764046-26-000019
FY 2025Yearly · 2025-12-31SegmentIntellectual Property Group799,400,000USD0001764046-26-000019
FY 2025Yearly · 2025-12-31SegmentLife Sciences And Healthcare Group389,800,000USD0001764046-26-000019
Q3 2025Quarterly · 2025-09-30ProductRe Occurring Revenues105,300,000USD0001764046-25-000116
Q3 2025Quarterly · 2025-09-30ProductSubscription Revenues405,400,000USD0001764046-25-000116
Q3 2025Quarterly · 2025-09-30ProductTransactional Revenues112,400,000USD0001764046-25-000116
Q3 2025Quarterly · 2025-09-30SegmentAcademia Government Group332,500,000USD0001764046-25-000116
Q3 2025Quarterly · 2025-09-30SegmentIntellectual Property Group197,800,000USD0001764046-25-000116
Q3 2025Quarterly · 2025-09-30SegmentLife Sciences And Healthcare Group92,800,000USD0001764046-25-000116
Q2 2025Quarterly · 2025-06-30ProductRe Occurring Revenues108,900,000USD0001764046-25-000096
Q2 2025Quarterly · 2025-06-30ProductSubscription Revenues405,700,000USD0001764046-25-000096
Q2 2025Quarterly · 2025-06-30ProductTransactional Revenues106,800,000USD0001764046-25-000096
Q2 2025Quarterly · 2025-06-30SegmentAcademia Government Group318,500,000USD0001764046-25-000096
Q2 2025Quarterly · 2025-06-30SegmentIntellectual Property Group202,500,000USD0001764046-25-000096
Q2 2025Quarterly · 2025-06-30SegmentLife Sciences And Healthcare Group100,400,000USD0001764046-25-000096
Q1 2025Quarterly · 2025-03-31ProductRe Occurring Revenues105,900,000USD0001764046-26-000058
Q1 2025Quarterly · 2025-03-31ProductSubscription Revenues388,600,000USD0001764046-26-000058
Q1 2025Quarterly · 2025-03-31ProductTransactional Revenues99,200,000USD0001764046-26-000058
Q1 2025Quarterly · 2025-03-31SegmentAcademia Government Group302,700,000USD0001764046-26-000058
Q1 2025Quarterly · 2025-03-31SegmentIntellectual Property Group192,700,000USD0001764046-26-000058
Q1 2025Quarterly · 2025-03-31SegmentLife Sciences And Healthcare Group98,300,000USD0001764046-26-000058
Q4 2024Quarterly · 2024-12-31ProductRe Occurring Revenues112,000,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31ProductSubscription Revenues407,000,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31ProductTransactional Revenues144,000,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31SegmentAcademia Government Group342,900,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31SegmentIntellectual Property Group209,100,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31SegmentLife Sciences And Healthcare Group111,000,000USDLegacy provider
FY 2024Yearly · 2024-12-31GeographyAsia Pacific507,500,000USD0001764046-26-000019
FY 2024Yearly · 2024-12-31GeographyEMEA667,800,000USD0001764046-26-000019
FY 2024Yearly · 2024-12-31GeographyNorth America1,381,400,000USD0001764046-26-000019
FY 2024Yearly · 2024-12-31ProductRe Occurring Revenues429,800,000USD0001764046-26-000019
FY 2024Yearly · 2024-12-31ProductSubscription Revenues1,626,800,000USD0001764046-26-000019
FY 2024Yearly · 2024-12-31ProductTransactional Revenues500,100,000USD0001764046-26-000019
FY 2024Yearly · 2024-12-31SegmentAcademia Government Group1,326,400,000USD0001764046-26-000019
FY 2024Yearly · 2024-12-31SegmentIntellectual Property Group811,400,000USD0001764046-26-000019
FY 2024Yearly · 2024-12-31SegmentLife Sciences And Healthcare Group418,900,000USD0001764046-26-000019
Q3 2024Quarterly · 2024-09-30ProductRe Occurring Revenues106,700,000USD0001764046-25-000116
Q3 2024Quarterly · 2024-09-30ProductSubscription Revenues411,100,000USD0001764046-25-000116
Q3 2024Quarterly · 2024-09-30ProductTransactional Revenues104,400,000USD0001764046-25-000116
Q3 2024Quarterly · 2024-09-30SegmentAcademia Government Group321,300,000USD0001764046-25-000116
Q3 2024Quarterly · 2024-09-30SegmentIntellectual Property Group199,800,000USD0001764046-25-000116
Q3 2024Quarterly · 2024-09-30SegmentLife Sciences And Healthcare Group101,100,000USD0001764046-25-000116
FY 2023Yearly · 2023-12-31GeographyAsia Pacific515,800,000USD0001764046-26-000019
FY 2023Yearly · 2023-12-31GeographyEMEA707,500,000USD0001764046-26-000019
FY 2023Yearly · 2023-12-31GeographyNorth America1,405,500,000USD0001764046-26-000019
FY 2023Yearly · 2023-12-31ProductRe Occurring Revenues444,600,000USD0001764046-26-000019
FY 2023Yearly · 2023-12-31ProductSubscription Revenues1,618,100,000USD0001764046-26-000019
FY 2023Yearly · 2023-12-31ProductTransactional Revenues566,100,000USD0001764046-26-000019
FY 2023Yearly · 2023-12-31SegmentAcademia Government Group1,323,300,000USD0001764046-26-000019
FY 2023Yearly · 2023-12-31SegmentIntellectual Property Group862,700,000USD0001764046-26-000019
FY 2023Yearly · 2023-12-31SegmentLife Sciences And Healthcare Group442,800,000USD0001764046-26-000019
FY 2022Yearly · 2022-12-31GeographyAsia Pacific499,200,000USD0001764046-25-000011
FY 2022Yearly · 2022-12-31GeographyEMEA698,300,000USD0001764046-25-000011
FY 2022Yearly · 2022-12-31GeographyNorth America1,462,300,000USD0001764046-25-000011
FY 2022Yearly · 2022-12-31ProductRe Occurring Revenues441,900,000USD0001764046-25-000011
FY 2022Yearly · 2022-12-31ProductSubscription Revenues1,618,800,000USD0001764046-25-000011
FY 2022Yearly · 2022-12-31ProductTransaction Revenues599,100,000USD0001764046-25-000011
FY 2022Yearly · 2022-12-31SegmentAcademia Government Group1,280,100,000USD0001764046-25-000011
FY 2022Yearly · 2022-12-31SegmentIntellectual Property Group927,100,000USD0001764046-25-000011
FY 2022Yearly · 2022-12-31SegmentLife Sciences And Healthcare Group452,600,000USD0001764046-25-000011
FY 2021Yearly · 2021-12-31GeographyAsia Pacific396,400,000USD0001764046-24-000016
FY 2021Yearly · 2021-12-31GeographyEMEA555,800,000USD0001764046-24-000016
FY 2021Yearly · 2021-12-31GeographyNorth America924,700,000USD0001764046-24-000016
FY 2021Yearly · 2021-12-31SegmentAcademia Government Group489,400,000USD0001764046-24-000016
FY 2021Yearly · 2021-12-31SegmentIntellectual Property Group974,300,000USD0001764046-24-000016
FY 2021Yearly · 2021-12-31SegmentLife Sciences And Healthcare Group413,200,000USD0001764046-24-000016
FY 2020Yearly · 2020-12-31SegmentAcademia Government Group384,700,000USD0001764046-23-000012
FY 2020Yearly · 2020-12-31SegmentIntellectual Property Group517,300,000USD0001764046-23-000012
FY 2020Yearly · 2020-12-31SegmentLife Sciences And Healthcare Group352,100,000USD0001764046-23-000012
FY 2019Yearly · 2019-12-31GeographyAsia Pacific233,004,000USD0001764046-22-000064
FY 2019Yearly · 2019-12-31GeographyEMEA278,738,000USD0001764046-22-000064
FY 2019Yearly · 2019-12-31GeographyNorth America463,041,000USD0001764046-22-000064
FY 2019Yearly · 2019-12-31SegmentIntellectual Property Group426,803,000USD0001764046-22-000064
FY 2019Yearly · 2019-12-31SegmentScience Group547,542,000USD0001764046-22-000064
FY 2018Yearly · 2018-12-31GeographyAsia Pacific221,979,000USD0001764046-21-000022
FY 2018Yearly · 2018-12-31GeographyEMEA273,744,000USD0001764046-21-000022

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.